Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Peregrine Pharmaceuticals, Inc.

Thumbshot of's website
http://www.peregrineinc.com

Peregrine Pharmaceuticals, Tustin CA, United States of America.

Peregrine Pharmaceuticals, Inc. (NASDAQ-PPHM) is a clinical stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV)
Peregrine Pharmaceuticals - Company Profile

Ticker -
PPHM - Financial Information



Avid Bioservices Expands Capabilities With Installation of Innovative Thermo Scientific HyClone Single-Use Bioreactor Systems

Monday 10th of November 2008 8:00

BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:

Google Custom Search
Browse other news from this organisation: Peregrine Pharmaceuticals, Inc.

Related Web-Links

(If any, Generated Automatically)
Google Custom Search

Source PR Newswire

PR Newswire Logo
www.prnewswire.co.uk

Browse news from 2008

Download PDF PDF Version

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.